myocardial damage
[대역어] 심근손상
[용어속성] Term
[용어속성] Term
Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection
SARS-CoV-2 감염 환자 집단에서 심근 손상의 특성화
Article
[키워드] age
Arrhythmias
bleeding
bleeding events
characterization
chronic
clinical outcomes
Cohort
cohort of patient
complications
concentrations
consecutive patients
covariates
COVID-19
criteria
Daño miocárdico
death
died
Elevation
English
European
Follow-up
Future
heart failure
hs-TNI
IMPROVE
independent
Infection
Injury
limitations
male
mechanical ventilation
median
Mild
Mortalidad
Mortality
myocardial damage
myocardial injury
onset of symptom
outcomes
overcome
Patient
patients with COVID-19
patients with SARS-CoV-2
prevalent
Prognosis
prognostic
Pronóstico
Research
Resultados
SARS-COV-2 infection
significantly
significantly more
Sin
Spanish
Stratification
thrombotic
time
troponin
troponin I
Troponina
[DOI] 10.1016/j.medcli.2021.02.001 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.medcli.2021.02.001 PMC 바로가기 [Article Type] Article
Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies
SARS-COV-2에 의한 심근 손상 : 신흥 메커니즘 및 요법
Review
[키워드] acting
action potential
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Apoptosis
arrhythmia
ATP
attack
autophagy
cause
Cell
cells
coronavirus
creating
damage
decrease
direct infection
docking
drug
early stage
early stages
Effect
effective
Endothelial cell
endothelial cells
energy
energy metabolism
evade
heart
host cell
Host immune response
Imbalance
immune cells
immune response
immunosuppressive
immunosuppressive therapy
induce
infect
Inflammation
inhibit
ion homeostasis
lead
leads
metabolism
myocardial damage
myocarditis
necroptosis
organ
Potential treatment
priming
programmed cell death
promote
protease
Protease inhibitor
protease inhibitors
Proteases
pyroptosis
receptor
Replication
respiratory
RNA-dependent RNA polymerase
ROS production
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 replication
severe acute respiratory syndrome Coronavirus
ssRNA
stages
therapy
treatment of viral infection
turn
Vesicle
Viral
viral clearance
viral docking
viral entry
viral replication
viroporin
[DOI] 10.3390/v13091880 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/v13091880 PMC 바로가기 [Article Type] Review
Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes
종양 괴사 인자-알파는 SARS-CoV2에 감염된 iPSC 유래 심근세포에서 바이러스 유입을 악화시킵니다
Article
[키워드] ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
aggravate
ameliorated
Analysis
angiotensin
Bioinformatics analysis
Cardiomyocytes
cardiovascular system
caused
Cell
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
COVID-19 patients
cytokine
Cytokine storm
elevated
enzyme
expressed
expression
Genes
host cells
Impact
in vitro
indicated
induce pluripotent stem cells
Infection
Inflammation
Mortality
Multi-organ damage
myocardial damage
neutralization
pandemic
platform
Proinflammatory cytokine
protease
Protein
pseudovirus
receptor
receptors
respiratory
SARS-CoV2
SARS-CoV2 infection
SARS-CoV2 pseudovirus
Serine
severe acute respiratory syndrome Coronavirus
significantly increased
stem cell
susceptibility
the cytokine storm
the viral nucleocapsid
TMPRSS2
TNF-α
TNF-α
TNF-α expression
transmembrane
Tumor
tumor necrosis
tumor necrosis factor-α
turn
upregulate
Viral
viral entry
[DOI] 10.3390/ijms22189869 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms22189869 PMC 바로가기 [Article Type] Article
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives
Review Article
[키워드] addition
Affect
aggregation
Anemia
atherosclerotic plaque
cardiovascular risk
cellular damage
clinical
Clinical course
condition
Coronary
coronary syndrome
coronavirus disease
COVID-19
COVID-19 patient
decrease
described
Effect
Endothelial cell
Endothelial dysfunction
expression
generate
Hyperinflammatory
hypoxic
induce
Injury
Local
Logistic
management
Microvascular thrombosis
Mortality
myocardial damage
Myocardial infarction
oxidative stress
oxygen
oxygen supply
Pathogenesis
pathophysiology
Patient
Perspective
Platelet
platelets count
potential mechanism
promote
Prothrombin time
prothrombotic
prothrombotic state
reflect
reported
Research
Sepsis
severe disease
Shock
subject
superoxide anions
systemic inflammatory response
therapeutic
thrombus formation
tissue
type 1 MI
von Willebrand factor
with COVID-19
[DOI] 10.1155/2021/4936571 PMC 바로가기 [Article Type] Review Article
[DOI] 10.1155/2021/4936571 PMC 바로가기 [Article Type] Review Article
Peculiaridade dos Pacientes com Arritmias Hereditárias na Pandemia pela COVID-19
Artigo de Revisão
[키워드] Aarrhythmogenic Right Ventricular Cardiomyopathy
acute respiratory syndrome
Arrhythmias
Brugada syndrome
Cardiomiopatia Arritmogênica do Ventrículo Direito
Cardiomyopathy
Catecholaminergic polymorphic ventricular tachycardia
caused
Clinical course
COVID-19
Diseases
Drug interactions
electrolyte disturbances
exacerbate
Factors
Fever
hidden
highlight
infecção
infectious condition
Long QT syndrome
myocardial damage
New coronavirus
Pandemia
pandemic
Patient
pelo coronavírus
Prevalence
respiratory infection
Síndrome de Brugada
Síndrome do QT Longo
SARS-CoV-2
Stress
syndrome
Tachycardia
Taquicardia Ventricular Polimórfica Catecolaminérgica
ventricular
[DOI] 10.36660/abc.20200391 PMC 바로가기 [Article Type] Artigo de Revisão
[DOI] 10.36660/abc.20200391 PMC 바로가기 [Article Type] Artigo de Revisão
Right Ventricular Strain Is Common in Intubated COVID-19 Patients and Does Not Reflect Severity of Respiratory Illness
우심실 긴장은 삽관된 COVID-19 환자에서 흔하며 호흡기 질환의 중증도를 반영하지 않습니다
Article
[키워드] acute respiratory distress
acute respiratory distress syndrome
Affect
age
airway
alveolar
Analysis
Atelectasis
Biomarkers
cardiac dysfunction
chest imaging
common
comorbid conditions
coronavirus disease
Coronavirus disease 2019
correlated
correlation
COVID-19
COVID-19 patient
COVID-19 patients
Critically ill
critically ill COVID-19 patients
demographics
determine
develop
disease severity
dysfunction
echocardiographic
had more
hypoxic
illness
induce
Inflammation
inflammatory markers
investigated
Laboratory
Lung compliance
Lung disease
lung mechanics
mechanical ventilation
mechanically ventilated
mechanically ventilated COVID-19 patients
medical record
medications
myocardial damage
myocarditis
Non-COVID-19
non-COVID-19 acute respiratory distress syndrome
outcome
Oxygenation
pathogenic mechanism
pathology
Patient
Plateau pressure
Pulmonary embolism
quantified
receiving
reduced
respiratory
respiratory distress
Respiratory distress syndrome
Respiratory failure
right
right ventricle
Right ventricular
RV dysfunction
secondary to
serum troponin
severity
strain
syndrome
thrombosis
Tidal volume
vasoconstriction
vasopressor requirements
Ventilation
ventilatory
ventilatory parameters
ventricular
Volume
[DOI] 10.1177/08850666211006335 PMC 바로가기 [Article Type] Article
[DOI] 10.1177/08850666211006335 PMC 바로가기 [Article Type] Article
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study
SARS-CoV-2, 심근 손상 및 염증: 대규모 임상 및 부검 연구에서 얻은 통찰력
Original Paper
[키워드] Abstract
age
analyzed
Antigen
association
Autopsy
autopsy study
Cardiac autopsy study
characterized
chronic
clinical
Clinical data
Cohort
Comorbidities
Comorbidity
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 disease
COVID-19 patients
Deceased
disease
Evidence
evidence of
First wave
form
histological analysis
Hospitalized
immunohistochemistry
Infection
Inflammatory
Injury
lung
Lungs
mechanism
Myocardial
myocardial damage
Myocardial inflammation
myocardial injury
myocarditis
Necrosis
objective
pandemic
Patient
patients
recorded
Result
RNA
RT-PCR
SARS-CoV-2
SARS-CoV-2 genome
SARS-COV-2 infection
SARS-CoV-2 viral
severe SARS
severe SARS-CoV-2
severity of COVID-19
supplementary material
the patient
tissue
Viral
viral antigens
viral genomes
viral persistence
[DOI] 10.1007/s00392-021-01910-2 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.1007/s00392-021-01910-2 PMC 바로가기 [Article Type] Original Paper
Identification of Causal Genes of COVID-19 Using the SMR Method
Genetics
[키워드] Analysis
applied
cardiac failure
cardiac muscle
Causal
complications of COVID-19
COVID-19
COVID-19 pathogenesis
COVID-19 patients
eQTL
FIVE
genetic cause
GWAS
identification
infected with SARS-CoV-2
instrumental variable
involved
Italian patient
knowledge
lung
mechanism
myocardial damage
Neurological disease
nine
observational study
occur
OGT
PANO1
potential molecular
PPA2
regulated
Research
risk
risk factor
SCD
SMR
SNP
Spanish
UQCRH
with COVID-19
[DOI] 10.3389/fgene.2021.690349 PMC 바로가기 [Article Type] Genetics
[DOI] 10.3389/fgene.2021.690349 PMC 바로가기 [Article Type] Genetics
T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study
T2 매핑 증가는 활성 COVID-19에서 심근 관련의 일반적인 이미징 바이오마커입니다: 심혈관 자기 공명 연구
Observational Study
Published on
Journal: Journal of Cardiovascular Magnetic Resonance [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제,
Journal: Journal of Cardiovascular Magnetic Resonance [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제,
[키워드] Abnormalities
abnormality
active phase
Artery
Biomarker
cardiovascular
Cardiovascular Magnetic Resonance
change
characterization
clinical
Cohort
collected
Comparisons
control group
Coronary arteries
coronavirus disease
Coronavirus disease 2019
correlation
COVID-19
COVID-19 diagnosis
COVID-19 patients
cTnT
decrease
Diagnosis
disease
Early detection
edematous
enrolled
Evidence
evidence of
Extracellular
fraction
gadolinium
healthy control
healthy controls
in vivo
individual
individuals
Infection
Inflammation
IQR
Laboratory
laboratory characteristics
laboratory findings
linear correlation
median
moderate
Myocardial
myocardial damage
Myocardial infarction
myocardial injury
myocardial involvement
myocarditis
Observational cohort study
Occurrence
parameters
Patient
patients
Pericarditis
positive linear correlation
positively correlated
predominant
prevalent
protocol
Quantitative imaging
referred to
relationship
resonance
Result
retrospective
risk
risk factor
SARS-CoV-2
selected
sensitivity
Sex
supplementary material
Symptomatic treatment
time interval
tissue
troponin
troponin T
Volume
volume fraction
[DOI] 10.1186/s12968-021-00764-x PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s12968-021-00764-x PMC 바로가기 [Article Type] Observational Study